Skip to main content
. 2020 Dec 7;10(12):e041529. doi: 10.1136/bmjopen-2020-041529

Figure 4.

Figure 4

Persistence to original treatment course for proton pump inhibitor (PPI) and histamine-2 receptor antagonist (H2RA) initiators.